Production of interleukin 1beta by human hematopoietic progenitor cells
- PMID: 8601632
- PMCID: PMC507231
- DOI: 10.1172/JCI118593
Production of interleukin 1beta by human hematopoietic progenitor cells
Abstract
The production of interleukin 1beta (IL-1beta) by human hematopoietic stem/progenitor cells was studied to explore the concept that these cells are not merely responders to stimuli from their microenvironment, but can themselves produce a powerful biomodulator. Cells with a CD34+ CD45RA(lo) CD71(lo) phenotype were purified from human umbilical cord blood and cultured one per well in serum-free medium with a mixture of cytokines. Cells that had divided over 2-5 d to form doublets were identified and the daughter cells were studied individually. 91% (460/506) of daughter cells had clonogenic potential. Analysis of these individual daughter cells by reverse transcription-polymerase chain reaction showed that 29% of them (14/48) were positive for IL-1beta mRNA. One of the cells that was strongly positive for IL-1beta mRNA had a sibling that generated 366,000 cells of multiple lineages after 14 d. IL-1beta converting enzyme mRNA, which is necessary to produce IL-1beta, was also detected by reverse transcription-polymerase chain reaction at the single-cell level. Moreover, enzyme immunoassay for mature secreted IL-1beta in culture supernatants demonstrated the production of IL-1beta protein by these cells. This was confirmed by fluorescent immunostaining of the cells for human IL-1beta which showed a significant portion of positive cells. Taken together, the results demonstrate the capacity of early hematopoietic cells to synthesize IL-1beta. The capacity of human hematopoietic stem/progenitor cells to produce IL-1beta may be involved in regulation of their proliferation and differentiation under certain circumstances and dysregulation of this process may be modified in leukemogenesis.
Similar articles
-
Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.Exp Hematol. 1998 Oct;26(11):1093-9. Exp Hematol. 1998. PMID: 9766451
-
Analysis of gene expression in small numbers of purified hemopoietic progenitor cells by RT-PCR.Stem Cells. 1995 May;13 Suppl 1:106-16. Stem Cells. 1995. PMID: 7488936
-
Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.Stem Cells. 2002;20(2):174-82. doi: 10.1634/stemcells.20-2-174. Stem Cells. 2002. PMID: 11897874
-
Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.Stem Cells. 2001;19(4):313-20. doi: 10.1634/stemcells.19-4-313. Stem Cells. 2001. PMID: 11463951
-
Clinical laboratory implications of single living cell mRNA analysis.Adv Clin Chem. 2004;38:239-57. doi: 10.1016/s0065-2423(04)38008-x. Adv Clin Chem. 2004. PMID: 15521194 Review. No abstract available.
Cited by
-
Interleukin-1 regulates hematopoietic progenitor and stem cells in the midgestation mouse fetal liver.Haematologica. 2009 Apr;94(4):462-9. doi: 10.3324/haematol.13728. Epub 2009 Feb 19. Haematologica. 2009. PMID: 19229053 Free PMC article.
-
Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis.Immunology. 2010 Jul;130(3):410-7. doi: 10.1111/j.1365-2567.2009.03243.x. Epub 2010 Feb 5. Immunology. 2010. PMID: 20141541 Free PMC article.
-
Dynamic protein associations define two phases of IL-1beta transcriptional activation.J Immunol. 2008 Jul 1;181(1):503-12. doi: 10.4049/jimmunol.181.1.503. J Immunol. 2008. PMID: 18566416 Free PMC article.
-
Interleukin-1-mediated hematopoietic cell regulation in the aorta-gonad-mesonephros region of the mouse embryo.Blood. 2008 Dec 15;112(13):4895-904. doi: 10.1182/blood-2007-12-123836. Epub 2008 Sep 19. Blood. 2008. PMID: 18805969 Free PMC article.
-
SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains.Oncotarget. 2017 May 16;8(20):33779-33795. doi: 10.18632/oncotarget.16810. Oncotarget. 2017. PMID: 28422713 Free PMC article.